KCNK10
MOLECULAR TARGETpotassium two pore domain channel subfamily K member 10
KCNK10 (potassium two pore domain channel subfamily K member 10) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting KCNK10
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Arachidonic Acid | 0.69 | 1 |
| 2 | Dehydroepiandrosterone Sulfate | 0.69 | 1 |
| 3 | Carvedilol | 0.69 | 1 |
| 4 | Linoleic Acid | 0.69 | 1 |
| 5 | Lysophosphatidylcholines Derivatives of PHOSPHATIDYLCHOLINES obtained by their partial hydrolysis which removes | 0.69 | 1 |
| 6 | Quinidine | 0.69 | 1 |
About KCNK10 as a Drug Target
KCNK10 (potassium two pore domain channel subfamily K member 10) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented KCNK10 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
KCNK10 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.